Sleep disorders and depression: brief review of the literature, case report, and nonpharmacologic interventions for depression

Luca, Antonina; Luca, Maria; Calandra, Carmela

doi:10.2147/cia.s47230

Cited by 36 publications

(22 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many antidepressants have untoward adverse effects on sleep, particularly causing or worsening insomnia, daytime sleepiness or sedation. Given the bidirectional relationship between psychiatric illness and insomnia, a medication that improves sleep quality may be a rational approach for improving the medical condition of psychiatric patients and in particular improve the quality of life of depresses subjects [ 55 , 56 ].…”

Section: Preclinical and Clinical Evidence On Effects Of Melatoninmentioning

confidence: 99%

Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders

Laudon

Frydman‐Marom

2014

IJMS

116

View full text Add to dashboard Cite

Several melatonin receptors agonists (ramelteon, prolonged-release melatonin, agomelatine and tasimelteon) have recently become available for the treatment of insomnia, depression and circadian rhythms sleep-wake disorders. The efficacy and safety profiles of these compounds in the treatment of the indicated disorders are reviewed. Accumulating evidence indicates that sleep-wake disorders and co-existing medical conditions are mutually exacerbating. This understanding has now been incorporated into the new Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). Therefore, when evaluating the risk/benefit ratio of sleep drugs, it is pertinent to also evaluate their effects on wake and comorbid condition. Beneficial effects of melatonin receptor agonists on comorbid neurological, psychiatric, cardiovascular and metabolic symptomatology beyond sleep regulation are also described. The review underlines the beneficial value of enhancing physiological sleep in comorbid conditions.

show abstract

Section: Preclinical and Clinical Evidence On Effects Of Melatoninmentioning

confidence: 99%

Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders

Laudon

Frydman‐Marom

2014

IJMS

116

View full text Add to dashboard Cite

show abstract

“…Similarly, while sleep deprivation and chronic fatigue have been highlighted as risk factors for the development of depressive symptoms and illness, there also does exist a bi-directional association ( Al-Abri, 2015 ). In addition to depression, sleep disturbance also has an impact on other psychiatric illness such as anxiety, and therefore sleep patterns warrant screening in individuals with psychiatric illness ( Krystal, 2012 ; Luca, Luca, & Calandra, 2013 ). Finally, unhealthy diet has been linked to depressive illness, including diets low in carbohydrates, altered protein diets which affect dopamine availability from amino acid breakdown, diets with low omega-3 fatty acids as well as those in vitamins and minerals ( O’Neil et al, 2014 ; Rao, Asha, Ramesh, & Rao, 2008 ).…”

Section: Resultsmentioning

confidence: 99%

Unhealthy Behaviors Among Canadian Men Are Predictors of Comorbidities: Implications for Clinical Practice

et al. 2018

View full text Add to dashboard Cite

Men’s poor health behaviors are an increasingly prevalent issue with long-term consequences. This study broadly samples Canadian men to obtain information regarding health behaviors as a predictor of downstream medical comorbidities. A survey of Canadian men included questions regarding demographics, comorbidities, and health behaviors (smoking and alcohol consumption, sleep and exercise behaviors, and dietary habits). Health behaviors were classified as either healthy or unhealthy based upon previous studies and questionnaire thresholds. Multivariate regression was performed to determine predictors for medical comorbidities. The 2,000 participants were aged 19–94 (median 48, interquartile range 34–60). Approximately half (47.4%) were regular smokers, 38.7% overused alcohol, 53.9% reported unhealthy sleep, 48.9% had low levels of exercise, and 61.8% had unhealthy diets. On multivariate analysis, regular smoking predicted heart disease (OR 2.08, p < .01), elevated cholesterol (OR 1.35, p = .02), type 2 diabetes (OR 1.57, p = .02), osteoarthritis (OR 1.43, p = .04), and depression (OR 1.62, p < .01). Alcohol overuse predicted hypertension (OR 1.40, p < .01) and protected against type 2 diabetes (OR 0.61, p < .01). Unhealthy sleep predicted hypertension (OR 1.46, p < .01), erectile dysfunction (OR 1.50, p = .04), and depression (OR 1.87, p < .01). Low levels of exercise predicted hypertension (OR 1.30, p = .03) and elevated cholesterol (OR 1.27, p = .05). Finally, unhealthy diet predicted depression (OR 1.65, p < .01). This study confirms the association of poor health behaviors and comorbidities common to middle-aged and older men. The results emphasize the potential scope of targeted gender-sensitized public awareness campaigns and interventions to reduce common male disease, morbidity, and mortality.

show abstract

“…Besides the numerous characteristics that were investigated in our study, it is interesting to investigate family structure and mental health in future research, as these factors have previously been associated with sleep duration. 42 , 46 …”

Section: Discussionmentioning

confidence: 99%

Characterizing Adult Sleep Behavior Over 20 Years—The Population-Based Doetinchem Cohort Study

Zomers

Hulsegge

Oostrom

et al. 2017

Sleep

View full text Add to dashboard Cite

Study Objectives:To describe sleep duration patterns of adults over a 20-year period; to compare sociodemographic, lifestyle, and health characteristics across these patterns; and to relate the patterns to sleep quality.Methods:The study population consisted of 3695 adults aged 20 to 59 years at baseline. Five measurements of self-reported sleep duration were used to compose seven patterns from 1987 to 2012: persistent short (≤6 hours), moderate (7–8 hours), or long (≥9 hours) sleep duration and several changing patterns (varying and became short, moderate, or long sleepers). Multinomial logistic regression analyses were used to compare characteristics across sleep duration patterns.Results:About 56% of the adults had persistent moderate sleep duration over 20 years. This group had a better sleep quality than the other groups. Of the adults who changed in their sleep duration (40%), 43% became a short sleeper. Sleep duration patterns that deviate from persistent moderate sleep duration were associated with physical inactivity during leisure time (odds ratios [ORs] and 95% confidence intervals [95% CIs] varied between 1.26 [1.04–1.53] and 1.58 [1.06–2.37]) and with poor self-rated health (ORs [95% CIs] varied between 1.50 [1.20–1.87] and 2.15 [1.48–3.12]).Conclusions:Nearly half of the adults did not have persistent moderate sleep duration over a 20-year period and more than one-sixth became short sleeper. This is reason for concern considering the adverse health status associated with short and long sleep duration. Leisure-time physical activity is a potential important target to prevent unfavorable changes in sleep duration over the life course.

show abstract

Sleep disorders and depression: brief review of the literature, case report, and nonpharmacologic interventions for depression

Cited by 36 publications

References 56 publications

Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders

Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders

Unhealthy Behaviors Among Canadian Men Are Predictors of Comorbidities: Implications for Clinical Practice

Characterizing Adult Sleep Behavior Over 20 Years—The Population-Based Doetinchem Cohort Study

Contact Info

Product

Resources

About